Murray Dallan bought SRPT
February 11, 2025 · Form 4 insider transaction
Murray Dallan bought 3,500 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,500
Price
$0.00
Total value
N/A
InsiderMurray Dallan
RoleOfficer
SecurityPerformance Restricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2025
Filing dateFebruary 13, 2025
Shares owned after17,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date.